BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Biogen Continues Bulking Up Its C-Suite With Appointment of Ex-Takeda Exec as CIO

  Mr. Hernon joins Biogen with more than 30 years of experience in IT and strategic leadership.

  December 4, 2017

   · 

  4 min read
• Biotech Bay

  AgeX Therapeutics CEO Michael D. West to Participate in Roundtable Panel on the Path Forward for Stem Cell Therapy at Termis Americas’ Annual Conference

  This year’s conference will focus on the theme, “The Path Forward for Regenerative Medicine: Traversing the Lab to the Patient.”

  December 4, 2017

   · 

  3 min read
• Biotech Bay

  Biotime’s Additional Renevia Data From the Successful Pivotal Trial Was Presented at the IFATS Conference

  The Renevia data was presented by primary investigator Ramon Llull, MD, PhD, Director of Stem Europe Mallorca Center, Mallorca, Spain at the “Plenary Session 2 - Clinical Studies with SVF.”

  December 4, 2017

   · 

  4 min read
• Business

  Revive Therapeutics Announces Update on Development of Datametrex Artificial Intelligence Component in Blockchain Enabled Patient-Focused Program for Medical Cannabis Sector

  Revive Therapeutics announced an update on the development of the Artificial Intelligence (“AI”) component for Revive’s proposed proprietary patient-focused program dedicated to the medical cannabis industry enabled by Blockchain technology.

  December 4, 2017

   · 

  7 min read
• Mettler Toledo’s Lab Expertise Library Offers White Papers, Webinars, and More

  he Lab Expertise Library offers users a wealth of ideas and tips on a wide range of topics.

  December 4, 2017

   · 

  1 min read
• Drug Development

  La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients With Beta Thalassemia

  LJ401-BT01 is a pivotal, multinational, multicenter, randomized, controlled study that is designed to enroll approximately 100 patients across 9 countries.

  December 4, 2017

   · 

  6 min read
• Business

  Marrone Bio Innovations Adds Three Commercial Managers for Southeast, West Coast, and Northeast and Mid-Atlantic Regions

  As seasoned experts in discovering, developing and commercializing naturally derived technologies, MBI has created an industry leading platform of pest management and plant health products.

  December 4, 2017

   · 

  5 min read
• Drug Development

  Zogenix Announces New Positive Efficacy and Safety Data from Pivotal Phase III Clinical Trial of ZX008 in Dravet Syndrome

  The updated Study 1 results, as well as additional data supporting the further investigation of ZX008 in refractory epilepsies, were presented at the 71st American Epilepsy Society Annual Meeting.

  December 4, 2017

   · 

  9 min read
• Atox Bio Closes $30M Investment

  The round was led by Arix Bioscience with participation from Adams Street Partners, Asahi Kasei and additional undisclosed investors.

  December 4, 2017

   · 

  3 min read
• Business

  Summit Therapeutics: Notice of Third Quarter Results

  The company will announce its financial results for the third quarter and nine months ended 31 October 2017 on 6 December 2017.

  December 4, 2017

   · 

  1 min read